Cas:26155-31-7 Morantel tartrate manufacturer & supplier

Chemical Name:Morantel tartrate

CAS.NO:26155-31-7

Synonyms:RUMATEL;trate;morantreltartrate;EINECS 247-481-5;1,4,5,6-Tetrahydro-1-methyl-2-(2-[3-methyl-2-thienyl]ethenyl)pyrimidine;MORTANELTARTRATE;(2R,3R)-2,3-Dihydroxysuccinic acid – 1-methyl-2-[2-(3-methyl-2-thienyl)vinyl]-1,4,5,6-tetrahydropyrimidine (1:1);MFCD00079449;MORANTEL TARTRATE HYDRATE;Morantel (+)-tartrate salt;banminthii;Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-[2-(3-methyl-2-thienyl)ethenyl]pyrimidine (1:1);Morantel hydrogen tartrate;Morantel tartrate;Morantel (tartrate)

Molecular Formula:C₁₆H₂₂N₂O₆S

Molecular Weight:370.421

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:334.6ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:158.90000

Exact Mass:370.119843

LogP:0.05460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like RUMATEL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Morantel (tartrate) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Morantel tartrate Use and application,trate technical grade,usp/ep/jp grade.

Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. Morantel tartrate manufacturer At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. Morantel tartrate supplier We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. Morantel tartrate vendor Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. Morantel tartrate factory Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.